Citations

Showing 10 of 108081 citations.

Role of patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain: a comprehensive narrative review
Shanthanna, Harsha , Provenzano, David Anthony, Kashir, Imad, Goel, Akash , Tian, Chenchen , Couban, Rachel , Levit, Tal , Provenzano, David Anthony , Hagedorn, Jonathan M , Narouze, Samer , Shanthanna, Harsha , Eldabe, Sam S. , Chang, Yaping , Adams, Daniel, Tian, Chenchen, Hagedorn, Jonathan M. , Narouze, Samer

Mayo Clinic

Regional Anesthesia & Pain Medicine | March 31, 2023 | Volume: 48 | Issue: 6 | Pages: 251-272

10.1136/rapm-2022-103820 | PMID 37001887 Get It

Background/importance Patient selection for spinal cord stimulation (SCS) therapy is crucial and is traditionally performed with clinical selection followed by a screening trial. The factors influencing patient selection and the importance of trialing have not been systematically evaluated. Objective We report a narrative review conducted to synthesize evidence regarding patient selection and the role of SCS trials. Evidence review Medline, EMBASE and Cochrane databases were searched for reports (any design) of SCS in adult patients, from their inception until March 30, 2022. Study selection and data extraction were carried out using DistillerSR. Data were organized into tables and narrative summaries, categorized by study design. Importance of patient variables and trialing was considered by looking at their influence on the long-term therapy success. Findings Among 7321 citations, 201 reports consisting of 60 systematic reviews, 36 randomized controlled trials (RCTs), 41 observational studies (OSs), 51 registry-based reports, and 13 case reports on complications during trialing were included. Based on RCTs and OSs, the median trial success rate was 72% and 82%, and therapy success was 65% and 61% at 12 months, respectively. Although several psychological and non-psychological determinants have been investigated, studies do not report a consistent approach to patient selection. Among psychological factors, untreated depression was associated with poor long-term outcomes, but the effect of others was inconsistent. Most RCTs except for chronic angina involved trialing and only one RCT compared patient selection with or without trial. The median (range) trial duration was 10 (0–30) and 7 (0–56) days among RCTs and OSs, respectively. Conclusions Due to lack of a consistent approach to identify responders for SCS therapy, trialing complements patient selection to exclude patients who do not find the therapy helpful and/or intolerant of the SCS system. However, more rigorous and large studies are necessary to better evaluate its role.
Thyroid Disease, Hypertension, and Pregnancy: The Need for Balance Illustrated in 2 Cases
Sousa, Círia, Kattah, Andrea G. , Stan, Marius, Kattah, Andrea, Garovic, Vesna D. , Stan, Marius N. , Fervenza, Fernando C.

Mayo Clinic

American Journal of Hypertension | March 30, 2023 | Volume: 36 | Issue: 7 | Pages: 411-414

10.1093/ajh/hpad030 | PMID 36996311 Get It

Abstract Thyroid dysfunction in pregnancy has been associated with hypertensive disorders of pregnancy and poor maternal and fetal outcomes. In this article, we describe two cases of significant thyroid dysfunction leading to new diagnoses of chronic hypertension in pregnancy and review physiologic changes in the thyroid gland, placenta and maternal cardiovascular system during pregnancy.
Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Surgical Anatomy of the Frontotemporal and Orbitozygomatic Craniotomies
Carlstrom, Lucas P. , Graffeo, Christopher S. , Leonel, Luciano CPC, Perry, Avital , Link, Michael J. , Peris-Celda, Maria, Leonel, Luciano P.C., Peris‐Celda, Maria

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 30, 2023 | Volume: 85 | Issue: 04 | Pages: 370-380

10.1055/a-2065-9495 | PMID 38966301 Get It

Abstract Introduction Although many neuroanatomic atlases have been published, few have detailed complex cranial approaches and pertinent anatomic considerations in a stepwise fashion intended for rapid comprehension by neurosurgery students, residents, and fellows. Methods Five sides of formalin-fixed latex-injected specimens were dissected under microscopic magnification. The frontotemporal and orbitozygomatic approaches were performed by neurosurgical residents and fellows at different training levels with limited previous experience in anatomical dissection mentored by the senior authors (M.P.C. and M.J.L.). Meticulous surgical anatomic dissections were performed until sufficient visual and technical completion was attained, with parameters of effectively demonstrating key surgical steps for educational training purposes. Following the completion of dissection and three-dimensional photography, illustrative case examples were reviewed to demonstrate the relative benefits and optimal applications of each approach. Results The frontotemporal and orbitozygomatic approaches afford excellent access to anterior and middle skull base pathologies, as well as the exposure of the infratemporal fossa. Key considerations include head positioning, skin incision, scalp retraction, fat pad dissection and facial nerve protection, true or false MacCarty keyhole fashioning, sphenoid wing drilling and anterior clinoidectomy, completion of the craniotomy and accessory orbital osteotomy cuts, dural opening, and intradural neurovascular access. Conclusion The frontotemporal and orbitozygomatic approaches are core craniotomies that offer distinct advantages for complex cranial operations. Learning and internalizing their key steps and nuanced applications in a clinical context is critical for trainees of many levels. The orbitozygomatic craniotomy in particular is a versatile but challenging approach; operative-style laboratory dissection is an essential component of its mastery and one that will be powerfully enhanced by the current work.
Utilization and reimbursement trends of osteopathic manipulative treatment for Medicare patients: 2000–2019
Starr, Evan G. , Hanson, Romney B. , Woolstenhulme, Jonathan B. , Roush, Andrew J. , Sperry, Nathan B., Wilde, Benjamin, Zapata, Isain , Smith, Jacob F. , Brooks, Amanda E.

Mayo Clinic

Journal of Osteopathic Medicine | March 30, 2023 | Volume: 123 | Issue: 6 | Pages: 309-315

10.1515/jom-2022-0174 | PMID 36996336 Get It

Abstract Context Osteopathic manipulative treatment (OMT) has been established as a beneficial and noninvasive treatment option for multiple conditions. With the total number of osteopathic providers tripling and the subsequent increase in osteopathic physician representation, we would expect the clinical use of OMT to increase accordingly. Objectives To that end, we evaluated the utilization and reimbursement of OMT services among Medicare beneficiaries. Methods Current procedural terminology (CPT) codes 98925 to 98929 were accessed from the Center for Medicare and Medicaid Services (CMS) from 2000 to 2019. These codes indicate OMT treatment, 98925 (1–2 body regions treated), 98926 (3–4 body regions treated), 98927 (5–6 body regions treated), 98928 (7–8 body regions treated), and 98929 (9–10 body regions treated). Monetary reimbursement from Medicare was adjusted for inflation, and total code volume was scaled to codes per 10,000 beneficiaries to account for the increase in Medicare enrollment. Results Overall OMT utilization declined between 2000 and 2019 by 24.5%. A significant downward trend in the utilization of CPT codes for OMT involving fewer body regions (98925–98927) was observed, and was contrasted by a slight upward trend in the use of codes for more body regions (98928, 98929). The adjusted sum reimbursement of all codes decreased by 23.2%. Lower value codes showed a higher rate of decline, whereas higher value codes changed less dramatically. Conclusions We conjecture that lower remuneration for OMT has disincentivized physicians financially and may have contributed to the overall decline in OMT utilization among Medicare patients, along with a decreased number of residencies offering specific training in OMT, and increased billing complexity. In considering the upward trend of higher-value code usage, it is possible that some physicians are increasing the comprehensiveness of their physical assessment and associated OMT to reduce the overall financial impact of reimbursement cuts.
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease
Stine, Jonathan G. , Long, Michelle T. , Corey, Kathleen E. , Sallis, Robert E. , Allen, Alina M. , Armstrong, Matthew J. , Conroy, David E. , Duarte‐Rojo, Andrés , Hallsworth, Kate , Hickman, Ingrid J. , Pugh, Christopher J. A. , Simon, Tracey G. , Hallsworth, Kate , Hickman, Ingrid J , Kappus, Matthew R , Keating, Shelley E , Rotman, Yaron , Vilar-Gomez, Eduardo , Wong, Vincent Wai-Sun , Schmitz, Kathryn H , Long, Michelle T , Allen, Alina M , Corey, Kathleen , Duarte-Rojo, Andres , Cuthbertson, Daniel James , Kappus, Matthew R. , Rotman, Yaron , Vilar‐Gómez, Eduardo , Wong, Vincent Wai‐Sun , Schmitz, Kathryn H.

Mayo Clinic

Hepatology Communications | March 30, 2023 | Volume: 7 | Issue: 4 | Pages: No page available

10.1097/hc9.0000000000000108 | PMID 36995998 Get It

Background and Aims: We present findings from the inaugural American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable, which was convened to evaluate the evidence for physical activity as a means of preventing or modifying the course of NAFLD. Approach and Results: A scoping review was conducted to map the scientific literature and identify key concepts, research gaps, and evidence available to inform clinical practice, policymaking, and research. The scientific evidence demonstrated regular physical activity is associated with decreased risk of NAFLD development. Low physical activity is associated with a greater risk for disease progression and extrahepatic cancer. During routine health care visits, all patients with NAFLD should be screened for and counseled about physical activity benefits, including reduction in liver fat and improvement in body composition, fitness, and quality of life. While most physical activity benefits occur without clinically significant weight loss, evidence remains limited regarding the association between physical activity and liver fibrosis. At least 150 min/wk of moderate or 75 min/wk of vigorous-intensity physical activity are recommended for all patients with NAFLD. If a formal exercise training program is prescribed, aerobic exercise with the addition of resistance training is preferred. Conclusions: The panel found consistent and compelling evidence that regular physical activity plays an important role in preventing NAFLD and improving intermediate clinical outcomes. Health care, fitness, and public health professionals are strongly encouraged to disseminate the information in this report. Future research should prioritize determining optimal strategies for promoting physical activity among individuals at risk and in those already diagnosed with NAFLD.
AAPM task group report 305: Guidance for standardization of vendor‐neutral reject analysis in radiography
Little, Kevin J. , Reiser, Ingrid , Apgar, Bruce, Dave, Jaydev K. , Fisher, Ryan , Hulme, Katie, Jafari, Mary Ellen, Marshall, Emily L. , Meyer, Stephen, Moore, Quentin T , Murphy, Nicole, Nishino, Thomas K. , Nye, Katelyn, Sabol, John M. , Tarbox, Lawrence , Uzenoff, Robert, Walz‐Flannigan, Alisa , Willis, Charles E., Little, Kevin , Marshall, Emily , Nishino, Thomas , Sensakovic, William, Reiser, Ingrid , Dalal, Poonam, O'Donnell, Kevin, Sánchez, Adrian A. , Sensakovic, William F. , Zhang, Jie

Mayo Clinic

Journal of Applied Clinical Medical Physics | March 30, 2023 | Volume: 24 | Issue: 5 | Pages: No page available

10.1002/acm2.13938 | PMID 36995917 Get It

AbstractReject rate analysis is considered an integral part of a diagnostic radiography quality control (QC) program. A rejected image is a patient radiograph that was not presented to a radiologist for diagnosis and that contributes unnecessary radiation dose to the patient. Reject rates that are either too high or too low may suggest systemic department shortcomings in QC mechanisms. Due to the lack of standardization, reject data often cannot be easily compared between radiography systems from different vendors. The purpose of this report is to provide guidance to help standardize data elements that are required for comprehensive reject analysis and to propose data reporting and workflows to enable an effective and comprehensive reject rate monitoring program. Essential data elements, a proposed schema for classifying reject reasons, and workflow implementation options are recommended in this task group report.
Prospective Assessment of the Prevalence of Enter Hyperoxalosis in Kidney Transplant Candidates
Mejia, Christina , Tariq, Anam , Alotaibi, Manal, Lakhani, Laila, Greenspan, Wendy , Naqvi, Fizza , Alasfar, Sami , Brennan, Daniel C. , Lakhani, Laila Saleem

Mayo Clinic

Transplantation Direct | March 30, 2023 | Volume: 9 | Issue: 4 | Pages: e1464

10.1097/txd.0000000000001464 | PMID 37009166 Get It

Background. Enteric hyperoxalosis (EH) is an emerging cause of kidney transplantation (KT) dysfunction. We sought to determine the prevalence of EH and factors that affect plasma oxalate (POx) among at-risk KT candidates. Methods. We prospectively measured POx among KT candidates evaluated at our center from 2017 to 2020 with risk factors for EH namely bariatric surgery, inflammatory bowel disease, or cystic fibrosis. EH was defined by a POx ≥10 μmol/L. Period-prevalence of EH was calculated. We compared mean POx across 5 factors: underlying condition, chronic kidney disease (CKD) stage, dialysis modality, phosphate binder type, and body mass index. Results. Of 40 KT candidates screened, 23 had EH for a 4-y period prevalence of 58%. Mean POx was 21.6 ± 23.5 μmol/L ranging from 0 to 109.6 μmol/L. 40% of screened had POx >20 μmol/L. Sleeve gastrectomy was the most common underlying condition associated with EH. Mean POx did not differ by underlying condition (P = 0.27), CKD stage (P = 0.17), dialysis modality (P = 0.68), phosphate binder (P = 0.58), and body mass index (P = 0.56). Conclusions. Bariatric surgery and inflammatory bowel disease were associated with a high prevalence of EH among KT candidates. Contrary to prior studies, sleeve gastrectomy was also associated with hyperoxalosis in advanced CKD. POx concentrations observed in EH reached levels associated with tissue and potentially allograft deposition. Concentrations can be as high as that seen in primary hyperoxaluria. More studies are needed to assess if POx is indeed a modifiable factor affecting allograft function in patients with EH.
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Morris, Michael J. , Hillman, David W. , Bobek, Olivia , Ryan, Charles J. , Antonarakis, Emmanuel S. , Bryce, Alan H. , Hahn, Olwen, Beltran, Himisha , Armstrong, Andrew J. , Schwartz, Lawrence B. , Langevin, Brooke , McGary, Eric C., Mehan, Paul, Goldkorn, Amir , Roth, Bruce J. , Xiao, Han , Watt, Colleen, Taplin, Mary‐Ellen , Halabi, Susan , Antonarakis, Emmanuel S. , Hillman, David W , Bobek, Olivia , Antonarakis, Emmanuel S , Bryce, Alan H , Beltran, Himisha , Armstrong, Andrew J , Beumer, Jan Hendrik , Goldkorn, Amir , Roth, Bruce J , Xiao, Han , Halabi, Susan , Small, Eric J , Morris, Michael J , Antonarakis, Emmanuel S , Heller, Glenn , Lewis, Lionel D. , Small, Eric J.

Mayo Clinic

Journal of Clinical Oncology | March 30, 2023 | Volume: 41 | Issue: 18 | Pages: 3352-3362

10.1200/jco.22.02394 | PMID 36996380 Get It

PURPOSE Enzalutamide and abiraterone both target androgen receptor signaling but via different mechanisms. The mechanism of action of one drug may counteract the resistance pathways of the other. We sought to determine whether the addition of abiraterone acetate and prednisone (AAP) to enzalutamide prolongs overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the first-line setting. PATIENTS AND METHODS Men with untreated mCRPC were randomly assigned (1:1) to receive first-line enzalutamide with or without AAP. The primary end point was OS. Toxicity, prostate-specific antigen declines, pharmacokinetics, and radiographic progression-free survival (rPFS) were also examined. Data were analyzed using an intent-to-treat approach. The Kaplan-Meier estimate and the stratified log-rank statistic were used to compare OS between treatments. RESULTS In total, 1,311 patients were randomly assigned: 657 to enzalutamide and 654 to enzalutamide plus AAP. OS was not statistically different between the two arms (median, 32.7 [95% CI, 30.5 to 35.4] months for enzalutamide v 34.2 [95% CI, 31.4 to 37.3] months for enzalutamide and AAP; hazard ratio [HR], 0.89; one-sided P = .03; boundary nominal significance level = .02). rPFS was longer in the combination arm (median rPFS, 21.3 [95% CI, 19.4 to 22.9] months for enzalutamide v 24.3 [95% CI, 22.3 to 26.7] months for enzalutamide and AAP; HR, 0.86; two-sided P = .02). However, pharmacokinetic clearance of abiraterone was 2.2- to 2.9-fold higher when administered with enzalutamide, compared with clearance values for abiraterone alone. CONCLUSION The addition of AAP to enzalutamide for first-line treatment of mCRPC was not associated with a statistically significant benefit in OS. Drug-drug interactions between the two agents resulting in increased abiraterone clearance may partly account for this result, although these interactions did not prevent the combination regimen from having more nonhematologic toxicity.
Ventricular arrhythmias in patients with prior aortic valve intervention: Characteristics, ablation and outcomes
Khalil, Fouad , Ahmad, Ali , Siontis, Konstantinos C. , Mulpuru, Siva K. , Munoz, Freddy Del‐Carpio , Cha, Yong‐Mei , Friedman, Paul A. , Munger, Thomas M. , Asirvatham, Samuel J. , Killu, Ammar M. , Siontis, Konstantinos C , Mulpuru, Siva K , Del-Carpio Munoz, Freddy , Cha, Yong-Mei , Friedman, Paul A , Munger, Thomas, Asirvatham, Samuel J , Killu, Ammar M , Khalil, Fouad , Toya, Takumi

Mayo Clinic

Journal of Cardiovascular Electrophysiology | March 30, 2023 | Volume: 34 | Issue: 5 | Pages: 1206-1215

10.1111/jce.15896 | PMID 36994918 Get It

AbstractIntroductionData regarding ventricular tachycardia (VT) or premature ventricular complex (PVC) ablation in patients with aortic valve (AV) intervention (AVI) is limited. Catheter ablation (CA) can be challenging given perivalvular substrate in the setting of prosthetic valves. We sought to investigate the characteristics, safety, and outcomes of CA in patients with prior AVI and ventricular arrhythmias (VA).MethodsWe identified consecutive patients with prior AVI (replacement or repair) who underwent CA for VT or PVC between 2013 and 2018. We investigated the mechanism of arrhythmia, ablation approach, perioperative complications, and outcomes.ResultsWe included 34 patients (88% men, mean age 64 ± 10.4 years, left ventricular (LV) ejection fraction 35.2 ± 15.0%) with prior AVI who underwent CA (22 VT; 12 PVC). LV access was obtained through trans‐septal approach in all patients except one patient who had percutaneous transapical access. One patient had combined retrograde aortic and trans‐septal approach. Scar‐related reentry was the dominant mechanism of induced VTs. Two patients had bundle branch reentry VTs. In the VT group, substrate mapping demonstrated heterogeneous scar that involved the peri‐AV area in 95%. Despite that, the site of successful ablation included the periaortic region only in 6 (27%) patients. In the PVC group, signal abnormalities consistent with scar in the periaortic area were noted in 4 (33%) patients. In 8 (67%) patients, the successful site of ablation was unrelated to the periaortic area. No procedure‐related complications occurred. The survival and recurrence‐free survival rate at 1 year tended to be lower in VT group than in PVC group (p = .06 and p = .05, respectively) with a 1‐year recurrence‐free survival rate of 52.8% and 91.7%, respectively. No arrhythmia‐related death was documented on long‐term follow‐up.ConclusionCA of VAs can be performed safely and effectively in patients with prior AVI.
Clinical characteristics and outcomes of cervical cancer in Asian Indian and Pakistani Americans (AIPA)
Gaire, Suman , Karki, Ujjwal , Budhathoki, Pravash , Shah, Anish , Yadav, Siddhartha

Mayo Clinic

International Journal of Cancer Care and Delivery | March 30, 2023 | Volume: 3 | Issue: Supplement 1 | Pages: No page available

10.53876/001c.73918 Get It